Clinical Evaluation of 103 Cases of Adenocarcinoma of the Uterine Cervix.
- Author:
Seung Hak YANG
;
Won Gue KIM
;
Un Dong PARK
- Publication Type:Original Article
- Keywords:
Adenocarcinoma;
Uterine cervix
- MeSH:
Adenocarcinoma*;
Cervix Uteri*;
Female;
Humans;
Lymph Nodes;
Neoplasm Metastasis;
Retrospective Studies
- From:Korean Journal of Gynecologic Oncology and Colposcopy
1994;5(4):15-23
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The purpose of this study was to investigate clinical charactoristics of adenocarcinoma of the uterine cervix. STUDY METHODS: This study is a retrospective analysis of 103 patients with adenocarcinoma of cervix treated at the Kosin Medical center forom 1984 to 1993. RESULTS: The distribution by stage of disease included FIGO stage I, 51(49.6%); stage II, 32(31%); Stage III, 17(16.5%);Stage IV, 3(2.9%). The 2-year survival results for patients with stage I was 93.5%; stage II was 72.4%;stage III was 46.2% and stage IV was none survived. And 4 year survival results,'83.3/o, 591% and 33.3/o in stage I, II and III, reqxetively. The 4-year survivel rate varied significantly according to tumor size and lymph nade metastasis status-below 2cm 84.2%, 2cm~4cm 75%, above 4cm 0%: (stage I);negative node 91.3%, positive node 40% (stage I). The results of resurrent rate according to clinical stage was 11.8%, 25.8%, 84.6% and 100 % in stage I, ll, III and lV, respectively. CONCLUSION: Treatment strategies should be based on the stage of disease, tumor size, lymph node metastasis status and recurrent.
